Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-22 Sale |
2022-11-25 4:41 pm |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
24,500 | $4.233 | $103,708 | 1,060,414 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-22 4:15 pm |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
22,261 | $4.3568 | $96,986 | 1,084,914 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-08 Tax Withholding |
2024-02-09 12:50 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered CHIEF EXECUTIVE OFFICER |
49,198 | $1.45 | 3,124,426 (Direct) |
View |
| 2024-01-09 Option Award |
2024-01-10 10:31 am |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Executive Officer |
1,753,125 | $1.93 | 4,926,749 (Direct) |
View |
| 2024-01-09 Option Award |
2024-01-10 10:31 am |
N/A 2034-01-08 |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Executive Officer |
1,753,125 | $0 | 4,926,749 (Direct) |
View |
| 2023-11-17 Tax Withholding |
2023-11-21 2:10 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
64,415 | $1.5 | 1,420,499 (Direct) |
View |
| 2023-02-08 Option Award |
2023-02-09 3:03 pm |
N/A 2033-02-07 |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
1,000,000 | $0 | 2,084,914 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:17 pm |
N/A 2030-08-17 |
Ayala Pharmaceuticals Inc. | ADXS | Bisker-Leib Vered Director |
3,981 | $0 | 3,981 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 4:15 pm |
N/A 2032-06-12 |
Ayala Pharmaceuticals Inc. | AYLA | Bisker-Leib Vered Director |
6,250 | $0 | 6,250 (Direct) |
View |
| 2022-02-18 Option Award(A) |
2022-02-23 5:30 pm |
N/A 2032-02-17 |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-18 7:13 pm |
N/A 2032-02-16 |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2021-11-16 Option Award |
2021-11-18 7:00 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
600,000 | $0 | 1,113,401 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:07 pm |
N/A 2031-06-09 |
Ayala Pharmaceuticals Inc. | AYLA | Bisker-Leib Vered Director |
6,250 | $0 | 6,250 (Direct) |
View |
| 2021-02-09 Option Award |
2021-03-01 10:34 am |
N/A 2031-02-09 |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered President & COO |
400,000 | $0 | 400,000 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 4:07 pm |
N/A 2030-08-17 |
Ayala Pharmaceuticals Inc. | AYLA | Bisker-Leib Vered Director |
8,750 | $0 | 8,750 (Direct) |
View |
| 2020-08-06 Option Award |
2020-08-10 8:52 pm |
N/A 2030-08-06 |
Compass Therapeutics Inc. | Bisker-Leib Vered Chief Operating Officer |
600,000 | $0 | 600,000 (Direct) |
View | |
Ownership |
2020-06-23 9:36 pm |
N/A N/A |
Compass Therapeutics Inc. | Bisker-Leib Vered Chief Operating Officer |
0 | $0 | 513,401 (Direct) |
View |